OR WAIT null SECS
April 02, 2010
As demand for global vaccine development and production grows, all eyes are turning to Asia.
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.
Interphex Showcase 2010.
The BIO convention, and healthcare reform, could re-energize biotech.
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and types of spending made in 2009 and planned for 2010.
April 01, 2010
Many small pharma/biopharma companies do not understand what a QMS is and the benefits offered by such a system. To be effective, there are several key strategic elements and systems that a QMS must incorporate.
Pfizer Invests In Nodality; SOCMA Approves New Members; And More.
March 25, 2010
Merck Ends Partnership With Dynavax; PhRMA Elects Officers; And More.
March 18, 2010
Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.
Three companies joined the University of Pittsburgh Medical Center's 21st Century Biodefense initiative to establish a flexible vaccine development and production facility.